Antineoplastic drug-use process at a rural hospital

This article describes the antineoplastic drug-use process and monitoring activities performed by the Department of Pharmacy at a 225-bed rural hospital. Documents developed and used in the process assist the pharmacist in assessing drug-related toxicity, in making recommendations for laboratory or system studies, and for organizing a therapeutic rationale for inpatients and out-patients. Involvement of pharmacists in oncology in rural or small institutions can be essential for maximal therapeutic monitoring and quality patient care. The importance of monitoring antineoplastics on a per patient basis is highlighted.